Gwynneth Thomas Ballentine, PhD, MBA

Director, Scientific Operations at Diversigen, Inc.
A Baylor College of Medicine Portfolio Company
Houston, TX


PhD in Molecular Pathology, Department of Lipid Sciences, 2010-2014
Molecular Medicine and Translational Science Graduate Program
Wake Forest University Graduate School of Arts and Sciences, Winston-Salem, NC

Dissertation: The Serine Hydrolase ABHD6 is a Critical Regulator of the Metabolic Syndrome

Masters of Business Administration, 2012-2014
Wake Forest University, Winston-Salem, NC

Bachelors of Science Degree in Biochemistry, 2006-2010
North Carolina State University, Raleigh, NC

Matriculation Year: 2010

Department: Pathology - Lipid Sciences 

  • Advisor: Dr. Mark Brown


    Quick Reference

    Find A Doctor Ways to Give
    Last Updated: 07-07-2016
    Comprehensive Cancer Centers National Designation is RenewedMagnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

    Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.